x Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Editorial Volume 4 Issue 9

Pharmacological Treatments and Development of SARS-CoV-2

Zaharaddeen Umar Na’abba and Abhishek Kumar Verma*

Department of Life Sciences, School of Science and Technology, Mewar University, Gangrar, Chittorgarh Rajasthan, India

*Corresponding Author: Abhishek Kumar Verma, Assistant Professor, Department of Life Sciences, School of Science and Technology, Mewar University, Gangrar, Chittorgarh, Rajasthan, India. E-mail: abhishekbairwa913@gmail.com

Received: July 26, 2020; Published: August 01, 2020

×

 Currently, the FDA for the treatment of COVID-19 pneumonia has approved no drugs or therapeutics vaccines. Some pharmacological treatment has gained emergency use authorization from FDA based on preliminary data displaying a faster time to recovery of hospitalized patients with severe COVID-19 infection. In this editorial, different pharmacological treatment that have been adopted for the management and treatment of COVID-19 pneumonia.

×

References

×

Citation

Citation: Zaharaddeen Umar Na’abba and Abhishek Kumar Verma. “Pharmacological Treatments and Development of SARS-CoV-2". Acta Scientific Pharmaceutical Sciences 4.9 (2020): 01-02.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


Contact US